T cell acute lymphoblastic leukemia (T-ALL) is an aggressive cancer of white blood cells which affects both children and adults. Many children with T-ALL can be cured with very intensive chemotherapy, but there are significant long term health problems associated with this therapy. A major goal for T-ALL is to develop new therapies that can help reduce the burden of treatment and offer cures to the approximately 20% of pediatric patients who succumb to the disease.

Vanderbilt University Medical Center
3319 West End Ave, Suite 100
Nashville, TN 37203-6869
United StatesPages
- 1
- 2
